Email this article Antibodies р-53 as a factor of the prognosis of chronic lymphocytic leukemia course
- Authors: Rogova ES1
-
Affiliations:
- Issue: Vol 13, No 5-6 (2013)
- Pages: 64-66
- Section: Articles
- URL: https://aspvestnik.ru/2410-3764/article/view/24796
- DOI: https://doi.org/10.17816/2072-2354.2013.0.5-6.64-66
- ID: 24796
Cite item
Full Text
Abstract
The article is devoted to a review of modern views on the pathogenesis, clinical course, diagnosis of chronic lymphocytic leukemia. The modern concept of the mutational status of patients with chronic lymphocytic leukemia is described. The possibility of optimizing the prognosis of chronic lymphocytic leukemia is shown.
References
- Caligaris-Cappio et F. al. Towards a better understanding of the biology of B-chronic lymphocytic leukemia. Sixth Meeting of the European Hematology Association, Frankfurt, Germany, 21-24 June 2001, Educational book, pp. 102-106
- Youinou P. et al. CD5 expression in human B-cell population. Immunol Today. 1999,20, 312-316
- HamblinT.J. et al. Unmutated IgV(H) genes are associated with more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94, 1848-1854
- Damle R.N. et al. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94, 1840-1847
- H. Dohner et al. Risk classification of chronic lymphocytic leukemia based on genetics. Sixth Meeting of the European Hematology Association, Frankfurt, Germany, 21-24 June 2001, Educational book, pp. 107-109).
- H. Dohner et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997, 89, 2516-2522
- Руководство по химиотерапии опухолевых заболеваний/ под ред. Н. И. Переводчиковой.-М.: Практическая медицина, 2011. - с. 321
- Болезни крови в амбулаторной практике/под ред. И.Л. Давыдкина.- М.: ГЭОТАР-Медиа, 2011.
- Rosenwald A, Chuang E, Davis R, et al. Fludarabine treatment of patients with chronic lymphocytic leuсemia induces a p53-dependent gene expression response. Blood 2004
- A. Roeber et al. P53 aberrations in B-CLL predict survival and are associated with in vivo resistance to therapy. Blood 2000, 96, 175b, abstr. 4463.
Supplementary files
